- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Global Cannabis's CannaLife, a BlockChain and Artificial Intelligence Social App for Medical Cannabis now on Apple Store and Google Play
Global Cannabis Applications Corp. (CSE: APP, FSE:2FA, OTCQB: FUAPF) is pleased to announce that CannaLife, a social engagement app for the medical cannabis community, is available for immediate download on Google Play and beta launch on Apple Store globally.
Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FSE:2FA, OTCQB:FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce that CannaLife, a social engagement app for the medical cannabis community, is available for immediate download on Google Play and beta launch on Apple Store globally.
As part of a Citizen Green Blockchain, CannaLife is designed to create conversations, share information, encourage education and build communities pertaining to medical cannabis on a single social platform. It is easy to setup and allows users to post content and tag topics across multiple platforms. Emoticons captures the feelings related to each post and users can join or create communities based on needs, questions and experience.
“I am delighted to announce that CannaLife, a core mobile application in the Citizen Green platform, is now available from Apple Store and Google Play,” said Brad Moore, CEO of GCAC. “CannaLife is the first medicinal cannabis-related social media platform of its kind, that allows us insights into the needs, concerns and desirers of both active med canna and potential users around the world. The launch of CannaLife is a significant milestone as this is the first step in creating a much sought after anonymous and secure user registry data. From regulator to Licensed Producers and canna product manufacturers, this highly valuable information will be a key part of development of new safe and healthy canna products for a global market. It is the first of many new digital tools to come from GCAC that will contribute to our revenue model.”
The CannaLife app will be preloaded with a base of users from Foro and Opinit apps, both target demographics for medical cannabis. Based on proprietary canna IP, CannaLife will use artificial intelligence to correlate in app inputs and behaviours against clinical benchmarks to match user profiles against specific canna product profiles.
We encourage both active and non-active medical cannabis users to download the mobile app and join the conversation. Contact us at info@cannappscorp.com for your iOS download.
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative data technologies for the cannabis industry. The Citizen Green platform is the world’s first end-to-end – from patient to regulator – medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence, reg tech, smart databases, blockchain and digital reward tokens, to qualify candidates for clinical studies. These technologies facilitate the proliferation of digital conversations by like-minded people in medical cannabis. Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles www.sedar.com and on the Canadian Securities Exchange’s website (www.thecse.com).
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone: 514-5619091
Email: bmoore@cannappscorp.com
For more information, please contact:
Corporate Communications
Telephone: 1.855.269.9554
Email: info@cannappscorp.com
www.cannappscorp.com
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
Click here to connect with Global Cannabis Applications Corp. (CSE:APP, FSE:2FA, OTCQB:FUAPF) for an Investor Presentation
Source: www.thenewswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.